🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this multi-center study is to assess the efficacy of headach...
Status
Terminated
Location
PAREXEL International, LLC
Start Date
2013-04-01
Trial ID
NCT01842633
Treatments Being Tested
The main objective of the study is to evaluate the bioequivalence of a new ...
Status
Completed
Location
CROSS Research S.A., Phase I Unit
Start Date
2016-06
Trial ID
NCT02902289
Treatments Being Tested
The purpose of the present study is to determine whether treatment of hemod...
Status
Terminated
Location
University of South Alabama
Start Date
2018-12-15
Trial ID
NCT03701074
Treatments Being Tested
This study will compare a fast-absorbing paracetamol plus caffeine formula ...
Status
Terminated
Location
University Clinical Research, Inc.
Start Date
2009-07
Trial ID
NCT01755702
This study is designed to assess bioequivalence between one test and two re...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2011-02
Trial ID
NCT01316978
The main objective of the study is to evaluate the bioequivalence of a new ...
Status
Completed
Location
CROSS Research S.A., Phase I Unit
Start Date
2016-05
Trial ID
NCT02902302
Treatments Being Tested
The present study will be conducted in order to assess bioequivalence of th...
Status
Completed
Location
SocraTec R&D GmbH Clinical Pharmacology Unit
Start Date
2016-09
Trial ID
NCT03018015
Treatments Being Tested
The purpose of this study is to find out whether compared to our standard l...
Status
Terminated
Location
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre
Start Date
2020-07-01
Trial ID
NCT03456817
Treatments Being Tested
The aim of this study is to assess disintegration of the new Aspirin disint...
Status
Completed
Location
Bio-Images Research Ltd
Start Date
2017-08-07
Trial ID
NCT03225352